Cardiometabolic Medicine
The need for consistent updates and agile content is imperative for today’s clinician to remain current on the continuum of scientific data. In no therapeutic area is this more essential than in “Cardiometabolic Medicine,” a new term meant to encompass the interconnected and debilitating diagnoses of diabetes mellitus, heart failure, coronary artery disease/acute coronary syndrome, progressive renal insufficiency, and related disorders such as hypertension, hyperlipidemia, and hyperkalemia. These areas are subject to frequent pivotal trial publications, guidelines updates, FDA action, and outcomes assessments.
Our Tweetorials
Your new source for free CE/CME via Twitter!
Each program provides 0.5hr – 1.0hr credit for physicians, pharmacists, and nurses.
Summary of Available Data on Specific DOAC Reversal and Nonspecific Factor Repletion in Patients with Anti-FXa-DOAC-Associated Hemorrhage
2) This 🆓program is accredited for 0.5h CE/#CME for #physicians #physicianassociates #nurses #nurespractitioners #pharmacists and is supported by a...
The Sleeping Giant: Type 2 Diabetes & Sleep Disorders
2) Our expert faculty is Dr Kevin Fernando @drkevinfernando, FRCGP FRCP Edin, FAcadMEd MSc Diabetes, GP with Specialist Interest in CVRM &...
AHA2022 UPDATE: META-ANALYSIS INDICATES SGLT2i SHOULD BE FOUNDATIONAL THERAPY IN CKD
2) This work was presented by Will Herrington @willkidney, @The_MRC @Kidney_Research UK funded AssocProf @Oxford_NDPH and representing the...
Anti-FXa-DOAC-Associated GI Hemorrhage: Which Patients Should Be Reversed?
2) I am Deborah Siegal MD MSc FRCOC @DebSiegal, a #hematologist @OttawaHospital, Tier 2 Canada Research Chair in Anticoagulant Management of...
HCM Prevalence, Pathophysiology, and Natural Course with and without Adequate Medical Treatment
2a) This program is intended for #healthcare providers and is supported by an educational grant from Bristol-Myers Squibb. Statement of...
CONTINUING THE CONVERSATION: Key Discussion Points of the ESOC22 Symposium on Managing aFXa-DOAC-Associated ICH
2) The outstanding faculty for this course included Thorsten Steiner (chair), Michiel Coppens, and Adrian Parry-Jones @adrianpj1. This #tweetorial...
Treatment Strategies for Basal Insulins to Manage Time-in-Range and Glucose Variability to Improve Outcomes in Persons with Diabetes: PART C
PART C: Strategies to Optimize Treatment Plans and Educate Persons with Diabetes 53) We are honored to have 2 #pharmacists and 1 #nutritionist guide...
Treatment Strategies for Basal Insulins to Manage Time-in-Range and Glucose Variability to Improve Outcomes in Persons with Diabetes: PART B
Part B: Clinical Review of Newer Longer-acting Insulins in Persons with Diabetes 28) We are honored to have 2 pharmacists and 1 nutritionist guide...
Treatment Strategies for Basal Insulins to Manage Time-in-Range and Glucose Variability to Improve Outcomes in Persons with Diabetes: PART A
Part A: A Closer Look into the Importance of the Role of the Diabetes Care and Education Specialist to Minimize Glucose Variability in Patients on...
Call to Action: Anticoagulation/Thrombosis Stewardship
2) #Physicians #Nurses #Pharmacists #physicianassociate #NPs earn 0.5h CE/#CME from @academiccme for following this 🧵...
@Cardiomet_CE on Twitter
Your only source for ACCREDITED SoMe-delivered
serialized professional cardiometabolic education. Physicians, nurses, pharmacists–come one, come all!
On Twitter at @cardiomet_ce, we present a series of tweetorials, Twitter-delivered case studies, and Twitter Journal Clubs, each accredited for 0.5hr – 1.0hr CE/CME. Programs are presented by expert faculty in engaging and fully interactive format. Our unique program harnesses the reach, up-to-the-minute currency, and accessibility of social media to deliver a constant flow of accredited, interactive, expert-delivered educational programs to a multidisciplinary and interprofessional audience of engaged clinicians.
Completed programs appear “unrolled” on this webpage, but to maximize the learning value of these innovative programs, please follow @cardiomet_ce.
Across #SGLT2i evidence, #HF RCTs enrolled some of oldest, frailest, & highest risk pts
Yet, consistent ↓ in *all-cause* & HF events w safest profile of any in current HF care
In HF, #NNT to prevent
CV ☠️ or HF 🏥 25
HF 🏥 28
CV ☠️ 88
All-Cause☠️92
Time to implement. @drjohnm
A review of current evidence regarding the epidemiology, pathophysiology, presentation, diagnosis and treatment of HFpEF
Heart Failure With Preserved Ejection Fraction https://ja.ma/3JtanrY via @JAMA_current part of @JAMANetwork
📌@escardio Quality Indicators for the care & outcomes of adults w/ pulmonary arterial hypertension
#PulmonaryHypertension #PAH #CardioTwitter #CardioEd #PositionPaper